Diabetes mellitus type 2

What is type 2 diabetes?

Type 2 diabetes is a metabolic condition in which the body's cells become progressively resistant to insulin — the hormone produced by the pancreas that allows glucose to enter cells for energy. As insulin resistance develops, the pancreas compensates by producing more insulin. Over time, this compensatory capacity is exhausted and blood glucose levels rise persistently, first to pre-diabetic levels, then to overt diabetes.

Unlike type 1 diabetes, which is autoimmune and involves complete insulin deficiency, type 2 diabetes is characterised by relative insulin deficiency combined with insulin resistance. It is strongly associated with obesity, physical inactivity, and metabolic syndrome, though genetic factors also play a significant role.

The long-term consequences of sustained elevated blood glucose affect virtually every organ (the heart, kidneys, eyes, nerves, and blood vessels) making early detection and management critically important.

Symptoms of type 2 diabetes

Type 2 diabetes often develops without obvious signs, but as blood glucose remains high, several key symptoms may emerge:

• Thirst and urination: excess glucose forces the kidneys to work harder, leading to dehydration and frequent bathroom trips.

• Fatigue: energy levels drop as cells struggle to use glucose efficiently.

• Blurred vision: fluid shifts in the eye lens due to high sugar levels.

• Slow healing: impaired blood flow and immune function delay recovery from cuts or sores.

• Infections: increased risk of skin, fungal, and urinary tract infections.

• Nerve changes: tingling or numbness in hands and feet (early neuropathy).

• Weight and hunger: unexpected weight loss and increased appetite as the body seeks alternative energy sources.

Because these symptoms are often subtle, many cases are only caught through proactive blood testing, which is vital for protecting your long-term cardiovascular and neurological health.

What causes type 2 diabetes?

Type 2 diabetes results from a combination of metabolic, genetic, and lifestyle factors that progressively impair insulin sensitivity and pancreatic function:

• Obesity and visceral fat: excess fat releases cytokines that directly block insulin signaling.

• Inactivity: lack of movement reduces the muscles' ability to absorb glucose.

• Genetics: a family history significantly raises risk due to inherited metabolic traits.

• Age: risk increases after age 45 as insulin production naturally declines.

• Metabolic syndrome: high blood pressure and cholesterol create a cycle of insulin resistance.

• Gestational diabetes: a history of diabetes during pregnancy raises lifetime risk.

• Sleep disorders: poor sleep and apnea impair glucose metabolism.

• Medications: certain drugs, like steroids, can disrupt glucose regulation.

Type 2 diabetes is directly detectable through blood testing and advanced body composition analysis, providing a clear picture of your metabolic health.

• HbA1c: the primary marker for average blood sugar over the last 2–3 months.

• Fasting glucose: direct measurement of blood sugar levels after fasting.

• Fasting insulin and HOMA-IR: identifies insulin resistance at its earliest stage, often before glucose levels rise.

• Triglycerides and HDL: dyslipidaemia (high triglycerides, low HDL) is a hallmark of insulin resistance and metabolic syndrome

• Total cholesterol and LDL: cardiovascular risk assessment; type 2 diabetes dramatically increases cardiovascular disease risk

• CRP: detects systemic inflammation that drives insulin resistance.

• Liver enzymes (ALT/GGT): screens for fatty liver disease, a major driver of diabetes risk.

• Creatinine, cystatin C, and eGFR: kidney function; diabetic nephropathy is one of the most serious long-term complications

• AMRA® analysis: measures visceral and liver fat, which are more precise predictors of diabetes risk than BMI.

By combining these markers, Elfcare identifies metabolic shifts early, allowing for interventions that protect your long-term cardiovascular and organ health.

Why early detection matters

The progression from insulin resistance to pre-diabetes to type 2 diabetes spans years, and is fully reversible at each stage with appropriate intervention. At the pre-diabetic stage, lifestyle changes such as weight loss, dietary modification, and increased physical activity, reduce progression to diabetes by over 50%.

Once type 2 diabetes is established, the focus shifts to preventing complications like cardiovascular disease, chronic kidney disease, peripheral neuropathy, retinopathy, and limb amputation, all of which are preventable with early, well-managed treatment. Identifying elevated insulin resistance or HbA1c early is one of the most impactful health findings a person can receive.

How Elfcare can help

Elfcare's blood panel is one of the most powerful tools available for type 2 diabetes detection — covering HbA1c, fasting glucose, fasting insulin, HOMA-IR, and a full metabolic profile. HOMA-IR in particular identifies insulin resistance years before HbA1c becomes abnormal, giving the widest possible window for intervention.

Our AMRA® body composition analysis quantifies visceral fat and liver fat with clinical precision, the metabolic risk factors most directly linked to insulin resistance development.

If our blood tests identify pre-diabetes, insulin resistance, or type 2 diabetes, we take care of further diagnostics or refer you to the appropriate specialist.